Literature DB >> 16643472

Positron emission tomography and molecular imaging of the prostate: an update.

Nathan Lawrentschuk1, Ian D Davis, Damien M Bolton, Andrew M Scott.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16643472     DOI： 10.1111/j.1464-410X.2006.06040.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  13 in total

1.  Role for (11)C-choline PET in active surveillance of prostate cancer.

Authors:  Oleksandr Boychak; Larissa Vos; William Makis; Francois-Alexandre Buteau; Nadeem Pervez; Matthew Parliament; Alexander J B McEwan; Nawaid Usmani
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

2.  Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer.

Authors:  Zsolt Szabo; Esther Mena; Steven P Rowe; Donika Plyku; Rosa Nidal; Mario A Eisenberger; Emmanuel S Antonarakis; Hong Fan; Robert F Dannals; Ying Chen; Ronnie C Mease; Melin Vranesic; Akrita Bhatnagar; George Sgouros; Steve Y Cho; Martin G Pomper
Journal:  Mol Imaging Biol       Date:  2015-08       Impact factor: 3.488

3.  Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent.

Authors:  Donika Plyku; Esther Mena; Steven P Rowe; Martin A Lodge; Zsolt Szabo; Steve Y Cho; Martin G Pomper; George Sgouros; Robert F Hobbs
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-02-19       Impact factor: 9.236

4.  Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-Based PET Radiotracers.

Authors:  Jimson W D'Souza; Harvey Hensley; Mohan Doss; Charles Beigarten; Michael Torgov; Tove Olafsen; Jian Q Yu; Matthew K Robinson
Journal:  J Nucl Med       Date:  2016-08-18       Impact factor: 10.057

5.  Significance of incidental focal uptake in prostate on 18-fluoro-2-deoxyglucose positron emission tomography CT images.

Authors:  E J Han; J H O; W H Choi; I R Yoo; S K Chung
Journal:  Br J Radiol       Date:  2010-11       Impact factor: 3.039

6.  Characterization of preclinical models of prostate cancer using PET-based molecular imaging.

Authors:  Sara Belloli; Elena Jachetti; Rosa M Moresco; Maria Picchio; Michela Lecchi; Silvia Valtorta; Massimo Freschi; Rodrigo Hess Michelini; Matteo Bellone; Ferruccio Fazio
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-11       Impact factor: 9.236

7.  Choline autoradiography of human prostate cancer xenograft: effect of castration.

Authors:  Hossein Jadvar; Alparslan Gurbuz; Xiankui Li; Antranik Shahinian; Peter S Conti
Journal:  Mol Imaging       Date:  2008 May-Jun       Impact factor: 4.488

Review 8.  Molecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancer.

Authors:  Sara Alcorn; Amanda J Walker; Nishant Gandhi; Amol Narang; Aaron T Wild; Russell K Hales; Joseph M Herman; Danny Y Song; Theodore L Deweese; Emmanuel S Antonarakis; Phuoc T Tran
Journal:  Int J Mol Sci       Date:  2013-07-16       Impact factor: 5.923

9.  Diagnostic role of fluorodeoxyglucose positron emission tomography-computed tomography in prostate cancer.

Authors:  Yiyan Liu
Journal:  Oncol Lett       Date:  2014-03-24       Impact factor: 2.967

10.  Abnormal 18F-FDG uptakes in the prostate due to two different conditions of urine reflux: a mimicker of prostate cancer.

Authors:  Kensuke Inamura; Yasushi Kaji; Setsu Sakamoto; Akinori Masuda; Takao Kamai
Journal:  Springerplus       Date:  2016-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.